CLINICAL_TRIALS
trial_result
· 2025-05-16
Clinical Trial Update: AlloStim® Immunotherapy Dosing Alone or in Combination With Cryoablation in Metastatic Colorectal Cancer [Phase 2]
Summary
Phase 2 trial evaluating AlloStim immunotherapy alone or with cryoablation in metastatic colorectal cancer has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mirror Biologics, Inc. | Conditions: Colorectal Cancer Metastatic | Phase 2 | Status: COMPLETED | Results posted: 2025-05-16